Epidemiology of pneumonia hospitalizations in Spain, 1995-1998

Journal of Infection

Volumn 44, Issue 2, 2002, Pages 84-87

  Gil, A ^a   San Martin M ^b   Carrasco, P ^a   Gonzalez A ^b  

^a UNIVERSIDAD REY JUAN CARLOS   (Spain)

^b AUTONOMOUS UNIVERSITY OF MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; COST CONTROL; FEMALE; GROUPS BY AGE; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH SURVEY; HIGH RISK POPULATION; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PUBLIC HEALTH SERVICE; SPAIN; STREPTOCOCCUS PNEUMONIA; VACCINATION;

EID: 0036063638     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1053/jinf.2002.0966     Document Type: Article

References (31)

1. Community-acquired pneumonia in the elderly patient: Clinical features, epidemiology and treatment
2. Pneumococcal vaccination. Four issues for western Europe
3. Epidemiology of community-acquired respiratory tract infections in adults: Incidence etiology, and impact
4. Mortalidad por enfermedades infecciosas en España: 1980-1995 (I)
5. Pneumococcal vaccine efficacy and associated cost savings
6. Epidemiology of primary varicella and herpes zoster hospitalizations: The pre-vaccination era
7. Impact of rotavirus disease in Spain: An estimate of hospital admissions due to rotavirus
8. Cost-effectiveness of pneumococcal vaccination of older people: A study in five western European countries
9. Pneumococcal vaccine
10. Accuracy of ICD-9-CM codes in detecting community-acquired pneumococcal pneumonia for incidence and vaccine efficacy studies
11. Incidence of community-acquired pneumonia and Chlamydia pneumoniae infection: A prospective multicentre study
12. Lugar de atención, etiología y tratamiento de las neumonías adquiridas en la comunidad de Palma de Mallorca
13. Aspectos epidemiológicos no resueltos de la neumonía adquirida en la comunidad en adultos
14. Prospective study of the aetiology and outcome of pneumonia in the community
15. Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland
16. Incidence of community-acquired pneumonia requiring hospitalization
17. Strategies for early discharge of the hospitalized patient with community-acquired pneumonia
18. A prospective randomized study of inpatient iv. antibiotics for community-acquired pneumonia. The optimal duration of therapy
19. Early switch from intravenous to oral antibiotics and early hospital discharge: A prospective observational study of 200 consecutive patients with community-acquired pneumonia
20. A prospective, multicenter study of a pneumonia practice guideline
21. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community
22. Reduction in hospital admissions for pneumonia in non-institutionalised elderly people as a result off influenza vaccination: A case-control study in Spain
23. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine
24. Pneumococcal polysaccharide vaccine efficacy
25. Influenza vaccination in 22 developed countries: An update to 1995
26. Pneumococcal vaccination in the United States and 20 other developed countries, 1981-1996
27. Immunization of elderly people with polyvalent pneumococcal vaccine
28. Ten-year durability and success of an organized program to increase influenza and pneumococcal vaccination rates among high-risk adults